Funds for Research and Development in Industry PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Funds for Research and Development in Industry PDF full book. Access full book title Funds for Research and Development in Industry by National Science Foundation (U.S.). Download full books in PDF and EPUB format.
Author: National Science Foundation (U.S.)
Publisher:
ISBN:
Category : Endowment of research
Languages : en
Pages : 126
Get Book Here
Book Description
Author: National Science Foundation (U.S.)
Publisher:
ISBN:
Category : Endowment of research
Languages : en
Pages : 470
Get Book Here
Book Description
Author: National Science Foundation (U.S.)
Publisher:
ISBN:
Category : Research
Languages : en
Pages : 124
Get Book Here
Book Description
Author: National Research Council
Publisher: National Academies Press
ISBN: 0309068924
Category : Political Science
Languages : en
Pages : 160
Get Book Here
Book Description
The science and engineering enterprise has continued to evolve, responding over the last decade to increased economic globalization, a post-cold war military, federal budget fluctuations, and structural changes in the way science and engineering are conducted and innovations are adopted. This report suggests ways to revise the data collection activities of the Science Resources Studies Division (SRS) of the National Science Foundation to better capture the current realities of R&D funding and S&E human resources. The report's recommendations would improve the relevance of the data on graduate education, the labor market for scientists and engineers, and the funding and conduct of research and development, and thus better meet the data needs of policymakers, managers, and researchers.
Author: National Science Foundation (U.S.)
Publisher:
ISBN:
Category : Endowment of research
Languages : en
Pages : 109
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Endowment of research
Languages : en
Pages : 8
Get Book Here
Book Description
Author: National Science Foundation (U.S.)
Publisher:
ISBN:
Category : Research
Languages : en
Pages : 60
Get Book Here
Book Description
Author: National Research Council
Publisher: National Academies Press
ISBN: 030917600X
Category : Political Science
Languages : en
Pages : 107
Get Book Here
Book Description
The United States faces a new challengeâ€"maintaining the vitality of its system for supporting science and technology despite fiscal stringency during the next several years. To address this change, the Senate Appropriations Committee requested a report from the National Academies of Sciences and Engineering and the Institute of Medicine to address "the criteria that should be used in judging the appropriate allocation of funds to research and development activities; to examine the appropriate balance among different types of institutions that conduct such research; and to look at the means of assuring continued objectivity in the allocation process." In this eagerly-awaited book, a committee of experts selected by the National Academies and the Institute responds with 13 recommendations that propose a new budgeting process and formulates a series of questions to address during that process. The committee also makes corollary recommendations about merit review, government oversight, linking research and development to government missions, the synergy between research and education, and other topics. The recommendations are aimed at rooting out obsolete and inadequate activities to free resources from good programs for even better ones, in the belief that "science and technology will be at least as important in the future as they have been in the past in dealing with problems that confront the nation." The authoring committee of this book was chaired by Frank Press, former President of the National Academy of Sciences (1981-1993) and Presidential Science and Technology Advisor (1977-1981).
Author:
Publisher:
ISBN:
Category : Federal aid to research
Languages : en
Pages : 588
Get Book Here
Book Description
Author: Tibor R. Machan
Publisher: Hoover Press
ISBN: 0817929428
Category : Political Science
Languages : en
Pages : 140
Get Book Here
Book Description
The contributors to this volume explore the implications of government funding of scientific research and offer alternatives to the heavy reliance on government support that research and development (R&D) currently enjoys. Each author squarely confronts the problems arising from the idea that government funding of R&D is and ought to be the norm.
Author: Patricia M. Danzon
Publisher: Oxford University Press
ISBN: 0199909261
Category : Business & Economics
Languages : en
Pages : 618
Get Book Here
Book Description
The biopharmaceutical industry has been a major driver of technological change in health care, producing unprecedented benefits for patients, cost challenges for payers, and profits for shareholders. As consumers and companies benefit from access to new drugs, policymakers around the globe seek mechanisms to control prices and expenditures commensurate with value. More recently the 1990s productivity boom of new products has turned into a productivity bust, with fewer and more modest innovations, and flat or declining revenues for innovative firms as generics replace their former blockbuster products. This timely volume examines the economics of the biopharmaceutical industry, with eighteen chapters by leading academic health economists. Part one examines the economics of biopharmaceutical innovation including determinants of the costs and returns to new drug development; how capital markets finance R&D and how costs of financing the biopharmaceutical industry compare to financing costs for other industries; the effects of safety and efficacy regulation by the Food and Drug Administration (FDA) and of price and reimbursement regulation on incentives for innovation; and the role of patents and regulatory exclusivities. Part two examines the market for biopharmaceuticals with chapters on prices and reimbursement in the US, the EU, and other industrialized countries, and in developing countries. It looks at the optimal design of insurance for drugs and the effects of cost sharing on spending and on health outcomes; how to measure the value of pharmaceuticals using pharmacoeconomics, including theory, practical challenges, and policy issues; how to measure pharmaceutical price growth over time and recent evidence; empirical evidence on the value of pharmaceuticals in terms of health outcomes; promotion of pharmaceuticals to physicians and consumers; the economics of vaccines; and a review of the evidence on effects of mergers, acquisitions and alliances. Each chapter summarizes the latest insights from theory and recent empirical evidence, and outlines important unanswered questions and areas for future research. Based on solid economics, it is nevertheless written in terms accessible to the general reader. The book is thus recommended reading for academic economists and non-economists, and for those in industry and policy who wish to understand the economics of this fascinating industry.
